NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

MWarlock, This treatment is NOT recommended for GBM, but for low-grade gliomas. Here's what the company recommends:
VORANIGO (40 mg tablets) is indicated for the treatment of adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2 (IDH2) mutation, as detected by an FDA-approved test, following surgery including biopsy, sub-total resection, or gross total resection.
So it appears not to be in competition with DCVax-L.